CT
TEVA icon

Coastline Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Coastline Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-29,790
Closed -$989K – 298
2017
Q2 		$989K Sell
29,790
-200
-0.7% -$6.19K 0.18% 167
2017
Q1 		$962K Buy
29,990
+1,040
+4% +$35.5K 0.18% 164
2016
Q4 		$1.05M Buy
28,950
+440
+2% +$17.6K 0.21% 151
2016
Q3 		$1.31M Hold
28,510
– – 0.26% 128
2016
Q2 		$1.43M Hold
28,510
– – 0.29% 125
2016
Q1 		$1.52M Buy
28,510
+175
+0.6% +$10.3K 0.33% 113
2015
Q4 		$1.86M Sell
28,335
-900
-3% -$55.6K 0.41% 100
2015
Q3 		$1.65M Buy
29,235
+75
+0.3% +$4.86K 0.38% 101
2015
Q2 		$1.72M Sell
29,160
-400
-1% -$24.7K 0.36% 107
2015
Q1 		$1.84M Hold
29,560
– – 0.38% 99
2014
Q4 		$1.7M Buy
29,560
+3,600
+14% +$201K 0.36% 105
2014
Q3 		$1.4M Hold
25,960
– – 0.37% 110
2014
Q2 		$1.36M Hold
25,960
– – 0.35% 114
2014
Q1 		$1.37M Sell
25,960
-200
-0.8% -$9.24K 0.36% 109
2013
Q4 		$1.05M Sell
26,160
-3,795
-13% -$149K 0.28% 126
2013
Q3 		$1.13M Buy
29,955
+2,280
+8% +$88.9K 0.33% 115
2013
Q2 		$1.08M Buy
+27,675
New +$1.08M 0.33% 113

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Coastline Trust's TEVA Position: Q3 2017 in Review

Coastline Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 29,790 shares — an estimated $989K sold.

Coastline Trust first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $1.86M in Q4 2015. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Coastline Trust reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Coastline Trust sold 29,790 Teva Pharmaceuticals shares in Q3 2017, an estimated $989K.
  • Coastline Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Coastline Trust's Teva Pharmaceuticals position peaked at $1.86M in Q4 2015.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Coastline Trust's 13F filing for Q3 2017, filed 17 Nov 2017.